AC   CVCL_2163
SY   PNT1a; PNT-1A; PNT1-a; PNT1/A
DR   BTO; BTO:0003068
DR   CLO; CLO_0008475
DR   CLDB; cl3926
DR   ECACC; 95012614
DR   GEO; GSM827411
DR   GEO; GSM1374835
DR   Wikidata; Q54947679
RX   PubMed=7558421;
RX   PubMed=11694337;
RX   PubMed=20215515;
RX   PubMed=21556542;
CC   Doubling time: 29.93 +- 1.29 hours (PubMed=21556542).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis.
CC   Derived from sampling site: Prostate.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 16
ST   D21S11: 27,28
ST   D8S1179: 10,12
ST   FGA: 24
ST   TH01: 6
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_4804 ! PNT1
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-10-20; Version: 18
RX   PubMed=7558421; DOI=10.1002/ijc.2910620613;
RA   Degeorges A., Hoffschir F., Cussenot O., Gauville C., Le Duc A.,
RA   Dutrillaux B., Calvo F.;
RT   "Recurrent cytogenetic alterations of prostate carcinoma and
RT   amplification of c-myc or epidermal growth factor receptor in
RT   subclones of immortalized PNT1 human prostate epithelial cell line.";
RL   Int. J. Cancer 62:724-731(1995).
RX   PubMed=11694337; DOI=10.1016/S0303-7207(01)00669-4;
RA   Avances C., Georget V., Terouanne B., Orio F. Jr., Cussenot O.,
RA   Mottet N., Costa P., Sultan C.;
RT   "Human prostatic cell line PNT1A, a useful tool for studying androgen
RT   receptor transcriptional activity and its differential subnuclear
RT   localization in the presence of androgens and antiandrogens.";
RL   Mol. Cell. Endocrinol. 184:13-24(2001).
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
RX   PubMed=21556542; DOI=10.3892/ijo.6.2.333;
RA   Berthon P., Cussenot O., Hopwood L., Leduc A., Maitland N.J.;
RT   "Functional expression of SV40 in normal human prostatic epithelial
RT   and fibroblastic cells - differentiation pattern of nontumorigenic
RT   cell-lines.";
RL   Int. J. Oncol. 6:333-343(1995).